EXPRESSION OF VIRAL PROTEINS IN TRANSGENIC MICE
转基因小鼠中病毒蛋白的表达
基本信息
- 批准号:3881816
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Vesiculovirus antibody formation autoimmune disorder central nervous system disorders congenital skeletal disorder cytokine receptors disease /disorder model gene expression genetic mapping genetic promoter element genetically modified animals glycoproteins human T cell lymphotropic virus type 1 immune tolerance /unresponsiveness immunization interleukin 2 laboratory mouse messenger RNA myelinopathy nervous system infection poly IC spastic paralysis tissue /cell culture vaccinia virus viral carcinogenesis virus envelope virus genetics virus infection mechanism virus protein
项目摘要
Individual viral proteins are expressed in transgenic mice in order to
answer two fundamental questions in viral pathogenesis: what are the
mechanisms of induction of an immune response against a virus and what
effect does a particular viral protein have on the metabolism of a cell in
vivo?
To address an example of the first question, induction of an immune
response, the envelope glycoprotein G of vesicular stomatitis virus,
serotype Indiana, was expressed in transgenics. When these mice are
immunized with purified G protein, or when challenged with a recombinant
vaccinia virus expressing this protein, only IgM and not IgG antibodies
able to neutralize wildtype Indiana VSV are formed. However,the response
with neutralizing antibodies is normal when the corresponding wildtype
Indiana VSV is used. Thus, tolerance breaks down, and autoimmunity is
established, when wildtype virus is used for immunization, and not when G
protein is presented in other ways. These mice may become a model for
those autoimmune phenomena of humans for which viral infections may be the
triggering event.
To address an example of the second question, we have expressed the
regulatory protein Tax of the human retrovirus HTLV-L known to be
associated with certain forms of T-cell leukemias, and tropical spastic
paraparesis. To date we have found that low level Tax expression in
transgenic mice may cause a thymic hypoplasia but no gross pathology.
Since in these mice the Tax protein is under the control of an inducible
promoter, we will be able in the future to study the effect of higher
levels of expression. However, in one transgenic line the Tax transgene is
apparently inserted into a host gene whose product is neccessary for
normal embryonic development of the vertebra: mice of this line, when
homozygous for the transgene, show a severe malformation of the vertebra
characterized by hemivertebrae, spina bifida occulta, fusions of vertebral
bodies, and short kinky tails. The molecular characterization of the
corresponding gene that we have mapped to mouse chromosome 11 is under
way.
在转基因小鼠中表达单个病毒蛋白,
回答病毒发病机制中的两个基本问题:
诱导针对病毒的免疫反应的机制,以及
特定的病毒蛋白质对细胞代谢有影响吗?
vivo?
为了解决第一个问题的一个例子,诱导免疫
反应,水泡性口炎病毒的包膜糖蛋白G,
血清型印第安纳州,在转基因中表达。 当这些老鼠
用纯化的G蛋白免疫,或者当用重组的
表达这种蛋白质的牛痘病毒,只有IgM抗体而没有IgG抗体
形成能够中和野生型印第安纳州VSV。然而,回应
中和抗体是正常的,
使用印第安纳州VSV。因此,耐受性被破坏,自身免疫被破坏。
当使用野生型病毒进行免疫时,而不是当G
蛋白质以其他方式存在。这些小鼠可能成为
病毒感染可能是人类自身免疫现象的原因,
触发事件。
为了解决第二个问题的一个例子,我们已经表达了
调节蛋白Tax的人逆转录病毒HTLV-L已知是
与某些类型的T细胞白血病和热带痉挛性
下肢轻瘫到目前为止,我们已经发现,
转基因小鼠可引起胸腺发育不全,但没有大体病理学。
因为在这些小鼠中,Tax蛋白是在一种可诱导的
促进剂,我们将能够在未来的研究效果更高
表达的水平。然而,在一个转基因系中,Tax转基因是
显然插入到宿主基因中,其产物是
椎骨的正常胚胎发育:当
转基因纯合子,显示脊椎严重畸形
以半椎体、隐性脊柱裂、椎体融合为特征
身体和弯曲的短尾巴的分子表征,
我们已经定位到小鼠11号染色体上的相应基因位于
路上了
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
H ARNHEITER其他文献
H ARNHEITER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('H ARNHEITER', 18)}}的其他基金
MESODERMAL HOMEODOMAIN PROTEIN DURING VERTEBRAL DEVELOPMENT
椎骨发育过程中的中胚层同源域蛋白
- 批准号:
6163105 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9981001 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9751102 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9397073 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
10223410 - 财政年份:2017
- 资助金额:
-- - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-BETA (REBI
使用 SC IFN-β (REBI) 预防 MS 患者中和抗体形成
- 批准号:
7951676 - 财政年份:2008
- 资助金额:
-- - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-β-AL
预防 SC IFN- 多发性硬化症患者中和抗体的形成
- 批准号:
7606036 - 财政年份:2006
- 资助金额:
-- - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7375053 - 财政年份:2005
- 资助金额:
-- - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7201220 - 财政年份:2004
- 资助金额:
-- - 项目类别:
Immunologic Mechanism of Inhibitor Antibody Formation in Hemophilia
血友病抑制剂抗体形成的免疫学机制
- 批准号:
6980810 - 财政年份:2003
- 资助金额:
-- - 项目类别:
INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA AND VON WILLEBRAND'S DISEASE
血友病和冯·维勒布兰德病中的抑制剂抗体形成
- 批准号:
6419444 - 财政年份:2000
- 资助金额:
-- - 项目类别: